Search

Is Part Of Biotechnology progress. Volume 39:Number 2(2023)

1. A genetic off‐target event in a site‐specific integration cell line expressing monoclonal antibody has no impact on commercial suitability. (19th January 2023)

Authors:
Tevelev, Barbara; Chambers, Andre; Ghosh, Swap; Zhang, Ying; Marzili, Lisa; Rouse, Jason C.; Han, Shu; Moffat, Mark; Scarcelli, John J.
Journal:
Biotechnology progress
Issue:
Volume 39:Number 2(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Accelerated CMC workflows to enable speed to clinic in the COVID‐19 era: A multi‐company view from the biopharmaceutical industry. (20th January 2023)

Authors:
Higgins, Matthew F.; Abu‐Absi, Nicholas; Gontarz, Elena; Gorr, Ingo H.; Kaiser, Klaus; Patel, Pramthesh; Ritacco, Frank; Sheehy, Patrick; Thangaraj, Balakumar; Gill, Tony
Journal:
Biotechnology progress
Issue:
Volume 39:Number 2(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Investigation of a failed DNA assay leads to identification of an unexpected contaminant in a commonly used chromatography buffer. (4th November 2022)

Authors:
Kuhns, Scott T.; Semin, David J.; Soice, Neil P.; Kappes, Andy; Wong, H. Edward; Hwang, Tsang‐Lin; Soto, Robert J.; Csordas, Andrew T.; Wu, Alexander; Martinez‐Cano, Diandra; Babayan, Melin; Pelayo, Yesenia; Hammond, Matthew R.; Nashed‐Samuel, Yasser; Goudar, Chetan T.
Journal:
Biotechnology progress
Issue:
Volume 39:Number 2(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search